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Abstract 
Gold nanoparticles (AuNPs) are produced for many applications but there is a lack of available data 
on their skin absorption. Experiments were performed using the Franz diffusion cell method with 
intact and damaged human skin. A physiological solution was used as receiving phase and 0.5 mL 
(1st exp) and 1.5 mL (2nd exp) of a solution containing 100 mgL-1 of AuNPs (15 and 45 mg cm-2, 
respectively) was applied as donor phase to the outer surface of the skin for 24 h. Skin absorption 
was dose dependent. Mean gold content of 214.0 ± 43.7 ng cm-2 and 187.7 ± 50.2 ng cm-2 were 
found in the receiving solutions of cells where the AuNPs solution was applied in higher 
concentration on intact skin (8 Franz cells) and on damaged skin (8 Franz cells), respectively. 
Twenty-four hours gold flux permeation was 7.8 ± 2.0 ng cm-2 h-1 and 7.1 ± 2.5 ng cm-2 h-1 in 
intact and damaged skin, respectively, with a lag time less than 1 hour. Transmission Electron 
Microscope analysis on skin samples and chemical analysis using Inductively Coupled Plasma-
Mass Spectrometry demonstrated the presence of AuNPs into epidermis and dermis. This study 
showed that AuNPs are able to penetrate the human skin in an in vitro diffusion cell system. 
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Introduction 
 
Over the past decades a huge interest in nanotechnologies has risen throughout the world because 
they have been considered revolutionary in many fields: Materials at the nanometer scale show 
different properties compared to the bulk forms with the same composition. In particular, 
nanoparticles with many different structures, due to their small size (100 nm or less) comparable to 
that of biological molecules, represent an enormous opportunity in the life sciences and in the 
medical field. Among these new nanocompounds, gold nanomaterials (AuNPs) are particularly 
attractive since their valuable size and shape-dependent properties are easy to control and modify; 
these characteristics offer powerful tools for the activity of the researchers and AuNPs have been 
proposed for a number of applications in many different fields (Penn et al. 2003; Gupta and Gupta 
2005; Neuberger et al. 2005; Chen et al. 2008). Many studies have been carried out on the use of 
modified gold nanomaterials in the imaging and therapy of tumors (El-Sayed et al. 2006; 
Bhattacharya and Mukherjee 2008); in the intracellular gene regulation for the control of protein 
expression in cells (Rosi et al. 2006), in the direct welding of connective tissues (Gobin et al. 2005; 
Ratto et al. 2009); but their use has also been proposed as immunostaining marker particles for 
electron microscopy, chromophores for immunoreactions (Mirkin et al. 1996), photocatalyst 
(Kamat 2002) and Raman sensors (Tian et al. 2002). AuNPs are also rising as a lead candidate in 
the transport of payloads within inside tissues and cells for drug delivery, gene therapy and cell 
imaging (Ghosh et al. 2008). 
AuNPs are stable in the body (Niidome et al. 2006) and so they have been largely used to study the 
tissue distribution, following administration through different routes (Semmler-Behnke et al. 2008; 
Sonavane et al. 2008a; Cho et al. 2009; Balasubramanian et al. 2010). However the safety of their 
use is a matter of  concern  and  more  data  are  needed  to  better understand their biocompatibility, 
their side-effects, and their fate in the body (Takahashi et al. 2006; Lewinski et al. 2008). In fact, a 
number of studies have reported that AuNPs can be toxic for cells because the uptake of gold 
clusters by different types of cells and their interaction with DNA have been demonstrated. 
Focusing on skin cells, Pernodet et al. (2006) investigated the effects of citrate/gold nanoparticles at 
different concentrations and exposure times on human dermal fibroblasts. They found that, as a 
result of the intracellular nanoparticle presence, actin stress fibers disappeared, thereby inducing 
major adverse effects on cell viability. Properties such as cell spreading and  adhesion,  cell  growth, 
and protein synthesis to form the extracellular matrix were altered dramatically, suggesting that the 
internal cell activities were damaged. On the contrary, Wang et al. (2008) tested the cytotoxicity of 
different size and shape gold nanomaterial on HaCaT keratinocytes and concluded that it is difficult 
to understand the cytotoxicity of gold nanomaterials individually, indeed spherical AuNPs were not 
inherently toxic to human skin cells, but gold nanorods were highly toxic due to the presence of the 
coating material. Finally, Mironava et al. (2010) described the interactions of AuNPs with human 
dermal fibroblasts and demonstrated that they can penetrate the plasma membrane and accumulate 
in large vacuoles in a time, size and concentration depending manner. Authors also provided 
evidences of some toxic effects as cytoskeleton filament disruption, decreased expression of the 
extracellular matrix proteins and decrease of the proliferation rates, but these detrimental effects on 
cell functions can reverse following AuNPs removal and cells can completely recover as a function 
of AuNPs size, concentration  and  exposure  time. 
Among the great number of applications, AuNPs would be an interesting carrier for transdermal 
delivery (Chen et al. 2008) but to our knowledge, there are no data on their skin permeation in in 
vitro system using human skin. Only Sonavane et al. (2008b) investigated the in vitro cutaneous 
penetration of three types of AuNPs differing in size (15 nm, 102 nm and 198 nm) using the Franz 
diffusion cell method with rat skin. AuNPs showed size-dependent permeation through rat skin: 15 
nm AuNPs showed higher permeation compared to 102 nm and 198 nm AuNPs. TEM study of rat 
skin revealed accumulation of smaller size nanoparticles in deeper skin regions whereas larger 
particles were observed mainly in epidermis and dermis. 
To investigate the potential of AuNPs skin absorption  in  vitro,  we  carried  out  a  series  of 
permeation experiments with human skin using a Franz static diffusion cell (Franz 1975). Using this 
technique, we investigated the total amount of gold permeating through human skin during a 24-h 
period. Experiments were run with intact skin as well as abraded skin following the Bronaugh and 
Stewart (1985) protocol to estimate the effect of skin lesions on the permeation rate. In this study, 
we applied the protocol adopted in the European project EDETOX (Evaluations and predictions of 
DErmal absorption of TOXic chemicals), a three-year research program (2001–2004) financially 
supported by the European Commission, and already used by our group to study the in vitro dermal 
absorption of silver nanoparticles (Larese Filon et al. 2009a). 
 
Materials and methods 
 
Chemicals 
 
All chemicals were analytical grade. Magnesium nitrate hexahydrate, palladium nitrate, sodium 
hydrogenphosphate, potassium dihydrogenphosphate, and hydrogen peroxide (30% v/v) were 
purchased from Carlo  Erba  (Milan,  Italy);  sodium  tetrachloroauric acid, trisodium citrate 
dihydrate, nitric acid (>69% v/v) and hydrochloric acid (36.5–38% v/v) from Sigma Aldrich (Milan, 
Italy). Water reagent  grade was produced with a Millipore purification pack system (milliQ water). 
The physiological solution used as the receptor fluid was prepared by dissolving 2.38 g of Na2HP04, 
0.19 g of KH2P04  and 9 g of NaCl into 1 L of milliQ water (final pH = 7.35). 
The synthetic sweat solution used as the donor fluid included 0.5% sodium chloride, 0.1% urea and 
0.1% lactic acid in milliQ water; pH 4.5 was adjusted with ammonia. 
 
Nanoparticle synthesis and characterization 
 
AuNPs were synthesized by reducing tetrachloroauric acid with sodium citrate as described by 
Grabar et al. (1995). Transmission Electron Microscopy (TEM) was used to evaluate the size and 
stability of nanoparticles before and after the experiments. 
Total gold concentration was analyzed by Inductively Coupled Plasma-Atomic Emission 
Spectroscopy (ICP-AES): 1 mL of AuNPs suspension was treated with 1 mL of Aqua Regia (a 
solution having concentrated nitric acid and concentrated hydrochloric acid mixed at a volume ratio 
of 1:3) at room temperature and the volume was adjusted to 10 mL with milliQ water. The gold 
solution was measured at a wavelength of 267,595 nm. A five-point standard 
curve was used for the analytical  measurements. The correlation coefficient of the standard  curve 
was 0.9989. The samples were analyzed by measuring against standard solutions for instrumental 
calibration. The coefficient of variation (CV) for the analysis was  less  than  3%  and  the  limit  of  
detection  was 0.050  mg  L-1.  The  determined  concentration  of gold  in  the  initial  nanoparticle  
suspension   was 100 ± 5 mg L-1  (n = 3). 
 
Preparation of skin membranes 
 
Human abdominal full thickness skin was obtained as surgical waste after the authorization of the 
local Ethical Committee. Prior to freezing, the subcutaneous fat was removed and the hair shaved 
with a razor. All the pieces of full thickness skin were stored in freezer at -25oC for a period up to, 
but not exceeding, two months. It has been shown that this method of storage does not damage the 
skin since no difference in permeability was observed between fresh and frozen segments of the 
same skin in a separate series of experiments (Franz 1975). Skin  integrity was tested before and 
after each experiment using electrical conductibility by means of a conductometer (Metrohm, 660, 
Metrohm  AG  Oberdorfstr. 68 CH-9100 Herisau) operating at 300 Hz and connected to two 
stainless steel electrodes (Fasano et al. 2009). The conductibility data in µS were converted into KΩ 
cm-2. Franz cells with a resistance lower than 3.95 ± 0.27 KΩ cm-2 were considered to be damaged 
and rejected as suggested by Davies et al. (2004). Donors were men and women with a wide range 
of age (41–71 years). 
 
In vitro diffusion system 
 
Percutaneous absorption studies were performed using static diffusion Franz cells (Franz 1975). 
The receptor compartment had a mean volume of 14.0 mL and was maintained at 32oC by means of 
circulation of thermostated water in the jacket surrounding the cell. This temperature value was 
chosen in order to reproduce the hand physiological temperature at normal conditions. The 
physiological solution used as the receptor fluid was prepared by dissolving 2.38 g of Na2HPO4, 
0.19 g of KH2PO4 and 9 g of NaCl into 1 L of milliQ water (final pH = 7.35). 
The concentration of the salt in the receptor fluid was approximately the same as the one found in 
the blood. The solution in each cell was continuously stirred using a Teflon-coated magnetic stirrer. 
Each piece of skin was clamped between the donor and the receptor compartment; the mean 
exposed skin area was 3.29 cm2  and the average thickness of the membranes was 1 mm. The 
experiments were carried out as follows: 
 
Experiment 1: At time 0, the exposure chambers of 8 Franz diffusion cells were filled with 0.5 mL 
of a solution containing 100 mg L-1 of AuNPs (15 mg cm-2) and diluted 1:3 with synthetic sweat at 
pH 4.5 to reproduce in vivo condition. The protocol used was the same of our previous paper 
(Larese Filon et al. 2009a). At 24 h, the dermal bathing solution was removed and the gold 
concentration was determined in each receiving chamber solution. 
 
Experiment 2: Experiment 1 was repeated using an abraded skin protocol as suggested by Bronaugh 
and Stewart (1985): The skin was abraded by drawing the point of a 19-gauge hypodermic needle 
across the surface (20 marks in one direction and 20 perpendicular).  
 
Experiment 3: At time 0, the exposure chambers of 8 Franz diffusion cells were filled with 1.5 mL 
solution containing 100 mg L-1  of nanoparticles solution (45 mg cm-2) diluted 1:3 with milliQ 
water. At selected intervals (4, 8, 16, 24 h) 1.5 mL of the dermal bathing solution was removed and 
analyzed. Each receptor sample was immediately replaced with an equal volume of fresh 
physiological solution. 
 
Experiment 4: Experiment 3 was repeated using the abraded skin protocol described above. 
Blanks: For each experiment, four Franz cells were added as blank. The blank Franz cells were 
treated as the other cells with the exception that no AuNPs was introduced to the exposure chamber. 
Experiments 1 and 2 were preliminary tests to evaluate nanoparticles permeation using the same 
protocol reported previously (Larese Filon et al. 2009a). Experiments 3 and 4 were performed using 
a higher gold concentration in milliQ water to avoid interference between AuNP and synthetic 
sweat. 
 
Skin content evaluation 
 
After the experiments 3 and 4, the skin pieces were removed from the diffusion Franz cells and 
treated in two different ways: Damaged skin samples were simply stored in freezer at -25oC, while 
intact skin samples were separated into  epidermis  and  dermis by heat shock immerging in water at 
60oC for 1 min. Before this operation, the stratum corneum (SC) of three intact skin samples was 
removed by stripping with PVC adhesive tape (Tesa-Beiersdorf AG, Ham- burg, Germany) in order 
to evaluate the gold content in different skin layers. Constant and uniform pres- sure (100 g cm-2) 
was applied on the tape for 5 sec by resting an appropriate weight on the area, and the tape than 
gradually removed from the skin in a one draw (Hostynek et al. 2001). It has been demonstrated 
that when applying the same pressure to the skin, after the first 2–20 strips, for a given skin site and 
test subject each tape remove a constant amount of SC (Hostynek et al. 2001). We chose to strip the 
skin only six times in order to prevent the damage of the epidermis after the 24-h period of exposure. 
All the skin fractions were collected and stored individually in freezer at -25oC for the following 
digestion and analysis. At the time of the analysis, the skin membranes were dried for 2 h at room 
temperature, then cut into sections and put into beakers with 25 mL of HNO3 70% v/v for digestion 
(amounts of skin were between 0.5 and 0.8 g). They were agitated for 20 h at 100oC (after 2 h they 
were added, drop by drop, of 5 mL of H2O2) until the remaining solutions were of 2 mL. The 
solutions were diluted with 25 mL of milliQ water for the analysis with ICP-MS. 
 
Analytical measurements 
 
The receptor fluid measurements were performed by Inductively Coupled Plasma-Mass 
Spectrometry (ICP-MS). An Agilent 7500ce (2005) instrument equipped with a collision cell was 
used for analysis. Calibration curves were obtained from four different standards at 1, 5, 10, 50 µg 
L-1. The limit of detection (LOD) for gold was 0.01 µg L-1 and the limit of quatification (LOQ) was 
0.03 µg L-1. The correlation coefficient (r) of the standard curve was 0.9985. The CV for the 
analysis of gold was always less than 3%. 
 
 
Data analysis 
 
Gold concentration data (µg cm-3) in the receptor solution (GRS) were converted to the total amount 
that penetrated (µg cm-2), considering the cell volume, the cell surface and the correction for 
dilution due to sample removal (1.5 mL) and than plotted against time. The slope of this plot gives 
the flux through skin (ng cm-2 h-1) and the intercept of the curve with the X-axis gives the lag time 
(h). 
Data analysis was performed using the statistical software SPSS for Windows (version 15.0). All 
data were reported as mean ± standard deviation (SD). 
The  difference  among  independent  data  was assessed by means of the Mann-Whitney and 
Kruskal Wallis tests. A p value of <0.05 was considered as the limit of statistical significance. 
 
Skin fixation protocol for TEM analysis 
 
After removal some skin samples were cut into smaller sections and fixed for 3 h in a solution of 
3% glutaraldheyde (Serva, Heildemberg, Germany) in 0.1M cacodylate buffer (pH 7.3). The fixed 
sections were washed twice (10 min each) with 0.1M cacodylate buffer and than post fixed with 1% 
osmium tetroxide for 1 h at 4oC. Post-fixed samples were dehydrated with an ascending ethanol 
series ending to 100% ethanol and then embedded in Down epoxy resin (DER332; Unione Chimica 
Europea, Milan, Italy) and DER732 (Serva). The last resin embedding was made under vacuum. 
Semi-fine and ultra thin sec- tions were prepared with an ultra microtome Leica Ultracut UCT 
(Leica Microsystem, Milan, Italy) equipped with a diamond blade Drukker 3 mm (Emme3, Milan, 
Italy). Semi-fine sections were observed with an optical  microscope  Leitz  Dialux 20 EB (Leica 
Microsystems, Milan, Italy) whereas ultra thin sections were double stained with lead citrate and 
uranyl acetate and observed with Trans- mission Electron Microscope (EM208; Philips, Heidhoven, 
The Netherlands) with an high definition acquisition system SIS Morada and a digital image 
acquisition system iTEM (FEI Italia, Milan, Italy). 
 
Results 
 
The AuNPs, visualized by TEM (Figure 1), were uniform in shape and size and they were as small 
as 12.6 ± 0.9 nm (number of measured nanoparticles: 345) and they showed the tendency to form 
aggregates. The  same  aggregates  were  present  in  the  donor solutions at the end of the 24 h 
period. In experiments 1 and 2, when AuNPs were applied in lower amount, gold passed through 
both the intact and the damaged human skin with a mean amount of 60.8 ± 25.3 ng cm-2 and 55.2 ± 
27.3 ng cm-2 at 24 h, respectively (Figure 2). 
In experiments 3 and 4, when AuNPs were applied in higher amount, analyses revealed a higher 
permeation  reaching  in  24  h  214.0  ± 43.7  ng  cm-2   and 187.8 ± 50.2 ng cm-2 in intact and 
damaged skin, respectively (Mann-Whitney test: p < 0.005 between experiments 1 and 3 and 2 and 
4; Figure 2). 
From experiment 3 and 4 the permeation profiles of AuNPs were obtained both for intact and 
damaged skin (Figure 3). Twenty-four hours gold flux permeation was 7.8 ± 2.0 ng cm-2 h-1 and 7.1 
± 2.5 ng cm-2 h-1 in intact and damaged skin, respectively (p = 0.4), with a lag time <1 h. 
The gold concentration in the damaged skin (exp. 4) was significantly higher in the intact skin (exp. 
3)  with  values  of  7.86  ±  4.00  µg  cm-2   and 1.82   ±  0.69   µg   cm-2,   respectively   (p   <  
0.009; Figure 4a). 
Figure 5 shows the gold content (means ± standard deviation) into  strip  numbers  ranging  from  
0.40  ± 0.05 µg cm-2  in the superficial strip (1st) to 0.17 ± 0.01 µg cm-2 into the deepest strip (6th) 
(p < 0.025). 
The gold content in the intact skin samples (exp. 3) decreased from the epidermis, 1.74 ± 0.68 µg 
cm-2, to the  dermis,  0.05  ±  0.02  µg  cm-2    (p  <  0.005, Figure 4b). The measurement of gold in 
the stratum corneum, epidermis and dermis of the intact skin revealed a decrease in gold content 
from the external to the internal site (p < 0.025). Finally, TEM investigation revealed the presence 
of AuNPs into stratum corneum, epidermis and dermis (Figure 6). 
 
Discussion and conclusion 
 
The present study investigated the skin absorption of AuNPs using full thickness human skin 
(epidermis and dermis): Experiments were conducted with both intact and damaged skin in an in 
vitro diffusion cell system. For the first time we have obtained results that proved  a  dose-
dependent  AuNPs  skin  penetration with TEM images into all layers of the human skin. AuNPs 
skin permeation is something new and there are very few data available in literature which is often 
scant and contradictory (Crosera et al. 2009; Baroli 2010).  Actually  different  types  of  NPs  have  
been tested,    and    in    particular    TiO2      (NANODERM 2007; Kiss et al. 2008), silver (Larese 
Filon et al. 2009a; Samberg et al. 2010), iron-based NPs (Baroli et  al.  2007),  quantum  dots  and  
carbon-based  NPs (Monteiro-Riviere  and  Inman  2006),  reporting  evidence of discrepancies in 
nanoparticle transcutaneous penetration. 
It is known that metallic ions (e.g., nickel and cobalt) are able to diffuse through the human skin 
(Larese Filon et al. 2004, 2007) and that silver nanoparticles have a permeation profile higher in the 
damaged skin than in the intact skin (Larese Filon et al. 2009a). Skin penetration can occur through 
pilosebaceus pores and sweat gland pores: NPs with diameter ranging between 7–20 nm are almost 
exclusively detected in the hair follicle infundibulum and even deeper (Schaefer et al. 1990; Lauer 
et al. 1996; Toll et al. 2004; Meidan et al. 2005). Vogt et al. (2006) showed that 40-nm particles 
were able to penetrate the perifollicular dermis through the hair follicle. For AuNPs, permeation 
through rat skin and intestine was already reported by Sonavane et al. (2008b), and our study 
confirms this capability also in human skin. 
The findings of our study suggest that human skin absorption of AuNPs could be relevant both 
through intact and damaged skin and there is not a statistically significant difference in the amount 
of gold permeated in the receiving phase of the two groups of Franz cells. Moreover, this 
permeation is influenced by the concentration of gold in the donor phase. In the 1st and 
2nd experiments the use of 15 µg cm-2  of gold in donor phases determined a lower NPgold 
absorption compared to that obtained in the 3rd and 4th experiments using 45 µg cm-2  of goldNP: 
The higher amount of gold (3 times) increased the permeation of about three times. There results 
could be also influenced by the effect of synthetic sweat on gold NP that could have increased their 
aggregation (with lower penetration). 
The evaluation of gold content in the skin revealed that gold concentration decreased from the 
superficial to the deeper skin layers and a significantly higher gold amount was found in damaged 
skin compared to the intact skin. Skin lesions increase only the amount of gold that remains in the 
skin and not the concentration in the receiving phase: this is probably due to a strong interaction 
between NPs and skin components (cells and extracellular matrix) that brake the NPs migration; the 
presence of abrasions put in direct contact NPs and skin components increasing their interaction and 
so the quantity of gold that remain in the skin. Another reason could be that AuNP cannot release 
ions in physiological conditions and this aspect can change the permeation properties in intact and 
damaged skin in respect to other metals such as silver, nickel or cobalt (Larese Filon et al 2009a, 
2009b) in which ions release influence skin permeation. 
TEM images permitted us to see clearly the presence of AuNPs in all the skin layers. Sample 
preparation for TEM analysis is quite long and complicated, and it can results in the generation of 
artifacts. The special attention posed in skin sample preparation, the  great number of NPs  found in 
all the skin layers, and the comparison of size and shape of NPs inside the skin with the initial 
colloid solution, have allowed us to confirm, at least qualitatively, the skin penetration of AuNPs. 
The chemical analysis performed using ICP-MS demonstrated the presence of gold in different skin 
layers. 
From a toxicological point of view, our findings are relevant because they demonstrate that AuNPs 
can permeate the human skin in a dose-dependent way reaching the derma where these 
nanoparticles can be available for systemic diffusion. It has been already demonstrated that NPs 
administered in the dermis migrated to regional lymph nodes, potentially via skin macrophages and 
Langerhans cells, raising potential concern for immunomodulation (Kim et al. 2004). At the same 
time, the ability of AuNPs to easily permeate the skin could be taken into account for important 
perspectives in biomedical application and this type of NPs might be a carrier for transdermal 
delivery. 
There are some limitations to this study that deserve attention. A limitation of our in vitro 
experiments is that the stratum corneum was exposed for 24 h. Excessive hydration is known to 
increase penetration of many compounds. Nevertheless, people have often mechanically damaged 
skin such as cuts and abrasions, which would make penetration sub-stantially higher. Another 
limitation is that the experiments were carried out with Franz cells in which skin was static: Human 
skin flexion has been suggested to lead to the increased translocation of small particles into the 
membrane (Tinkle et al. 2003; Rouse et al. 2007) and for this reason, in this case, the in vitro results 
can underestimate the real situation. A third limitation is that the skin samples in this type of tests is 
dead tissue, and thus there is a lack regarding the possible active processes that involve living cells; 
on the other hand, a number  of  studies  confirmed the usefulness of the in vitro experiments in the 
evaluation and prediction of percutaneous penetration  (EDETOX  2000) 
In conclusion, this experimental study showed that AuNPs can permeate the skin in greater amount 
than other NPs, such us silver nanoparticles (Larese Filon et al. 2009a), in an in vitro diffusion 
system. Moreover, the AuNPs cannot release Au ions in physiological condition, this penetration 
happens only  for  NPs.  This  is  the  most  important  result compared to  that  obtained  using  
silver  (Larese Filon et al. 2009) or other metal NPs that can be absorbed through the skin easily 
because the high surface can increase ionization. 
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Figure 1. AuNPs visualized by TEM 
 
 
 
Figure 2.  AuNPs permeation at 24 hours in intact and damaged skin (exp. 1–2 and exp. 3–
4) 
 
 
Figure 3.  AuNPs permeation profiles in intact and damaged skin (exp. 3–4) 
 
 
 
Figure 4.  (a) Gold content (exp. 3–4) into damaged and intact skin (means and standard 
deviation; *p < 0.009); (b) Gold content (exp. 3) into epidermis and dermis of intact skin 
samples (means and standard deviation; *p < 0.005) 
 
 
 
 
 
Figure 5.  Gold content (exp. 3) into stratum corneum tape stripping (means and standard 
deviation; *p < 0.025). From 1st more superficial to 6th more deep 
 
 
 
Figure 6.  (a) TEM micrograph of AuNPs-treated skin sample (Barr = 10 mm). (b, c, d) 
Some details of the stratum corneum (b, c.), and of the dermis (d) Black arrows show gold 
nanoparticles in the tissue. (Barr = 200 nm) 
 
 
 
 
